Valsartan and Hydrochlorothiazide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
82868-054 -
Package NDC
82868-054-30 -
Application number
ANDA203145 -
SPL ID
5502ebf5-b02f-5b67-e063-6294a90a2aeb -
SPL set ID
191d5710-7b8a-0b61-e063-6394a90afd41 -
UNII
80M03YXJ7I -
UNII
0J48LPH2TH -
RxCUI
349353
What the source publishes
- Labeler
- Northwind Health Company, LLC
- Active ingredients
- Valsartan and Hydrochlorothiazide
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Valsartan and Hydrochlorothiazide",
"splId": "5502ebf5-b02f-5b67-e063-6294a90a2aeb",
"labels": [
{
"setId": "191d5710-7b8a-0b61-e063-6394a90afd41",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=191d5710-7b8a-0b61-e063-6394a90afd41",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=191d5710-7b8a-0b61-e063-6394a90afd41"
}
],
"routes": [
"ORAL"
],
"labeler": "Northwind Health Company, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (82868-054-30)",
"package_ndc": "82868-054-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240521"
}
],
"productId": "82868-054_5502ebf5-b02f-5b67-e063-6294a90a2aeb",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "82868-054",
"deaSchedule": null,
"genericName": "Valsartan and Hydrochlorothiazide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VALSARTAN",
"strength": "160 mg/1"
},
{
"name": "HYDROCHLOROTHIAZIDE",
"strength": "25 mg/1"
}
],
"applicationNumber": "ANDA203145",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240521",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000070",
"N0000175561",
"N0000175359",
"N0000175419",
"M0471776"
],
"unii": [
"80M03YXJ7I",
"0J48LPH2TH"
],
"rxcui": [
"349353"
],
"spl_set_id": [
"191d5710-7b8a-0b61-e063-6394a90afd41"
],
"pharm_class_cs": [
"Thiazides [CS]"
],
"pharm_class_pe": [
"Increased Diuresis [PE]"
],
"pharm_class_epc": [
"Angiotensin 2 Receptor Blocker [EPC]",
"Thiazide Diuretic [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Northwind Health Company, LLC"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:82868-054_5502ebf5-b02f-5b67-e063-6294a90a2aeb"